ARCHIVED - Invasive Pneumococcal Disease

 


Nationally notifiable since 2000

1.0 National Notification

Only confirmed cases of disease should be notified.

2.0 Type of Surveillance

Routine case-by-case notification to the federal level

Enhanced case-by-case notification to International Circumpolar Surveillance in participating Northern regions

Enhanced active case-by-case notification by paediatric tertiary care hospitals involved in the Immunization Monitoring Program, Active (IMPACT)

3.0 Case Classification

3.1 Confirmed case

Clinical evidence of invasive disease (see section 5.0) with laboratory confirmation of infection:

  • isolation of Streptococcus pneumoniae from a normally sterile site (excluding the middle ear and pleural cavity)
    OR
  • demonstration of S. pneumoniae DNA from a normally sterile site (excluding the middle ear and pleural cavity)

3.2 Probable case

Clinical evidence of invasive disease with no other apparent cause and with nonconfirmatory laboratory evidence:

  • demonstration of S. pneumoniae antigen from a normally sterile site (excluding the middle ear and pleural cavity)

4.0 Laboratory Comments

Sputum and bronchial lavages are not considered sterile specimens.

Demonstration of S. pneumoniae DNA or antigen does not permit determination of serotype. Serotyping is carried out in a reference laboratory and is important for monitoring changes in disease epidemiology, including the impact of vaccination programs and serotype replacement.

5.0 Clinical Evidence

Clinical illness associated with invasive disease manifests itself mainly as pneumonia with bacteremia, bacteremia without a known site of infection, and meningitis. Pneumonia without bacteremia is not notifiable.

6.0 ICD Code(s)

6.1 ICD-10 Code(s)

A40.3
Septicaemia due to S. pneumoniae
B95.3
S. pneumoniae as the cause of diseases classified elsewhere, e.g.:
  • I30.1 Infective pericarditis
  • K65.0 Acute peritonitis
  • M00.8 Arthritis and polyarthritis due to other specified bacterial agents
  • O85 Puerperal sepsis
  • P23.6 Congenital pneumonia due to other bacterial agents
G00.1
Meningitis due to S. pneumoniae
J13
Pneumonia due to S. pneumoniae
M00.1
Pneumococcal arthritis and polyarthritis

6.2 ICD-9/ICD-9CM Code(s)

038.2
Septicaemia due to S. pneumoniae
041.2
S. pneumoniae of unspecified site and as the cause of diseases classified elsewhere, e.g.:
  • 420.9 Infective pericarditis
  • 711.0 Pyogenic arthritis
567.1
Pneumococcal peritonitis
320.1
Meningitis due to S. pneumoniae
481
Pneumonia due to S. pneumoniae
711.0
Pneumococcal arthritis and polyarthritis

7.0 Type of International Reporting

8.0 Comments

Probable case definitions are provided as guidelines to assist with case finding and public health management, and are not for national notification purposes.

9.0 References

Laboratory Centre for Disease Control. Preventing pneumococcal disease: a Canadian consensus conference. CCDR 1999;25:25-35.

10.0 Previous Case Definitions

Case definitions for diseases under national surveillance. CCDR 2000;26(S3).

Date of Last Revision/Review:

May 2008


Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: